The Aspen Ovestin sale will transfer European commercial rights to Ennogen Healthcare International for €197 million, while Aspen retains manufacturing and supply contracts. Wholly owned subsidiary Aspen Global will sell the commercialisation rights and associated intellectual property. The price equates to approximately R3.7 billion, with related inventory adding an estimated €4 million. However, completion depends on Ennogen’s funding arrangements becoming…
Tag: Women’s Health
-
Diabetes Deaths In SA Signal Urgent Public Health Emergency
Diabetes deaths in SA have risen sharply, and the disease has become one of South Africa’s most serious public health threats. New mortality figures show that it was the country’s leading underlying natural cause of death in 2023. According to death notification data processed by Stats SA and reviewed by the Diabetes Alliance, diabetes accounted for 27,692 deaths. That represented…
-
HPV Vaccination: School Vaccination Programme Cuts Risk
South Africa’s HPV vaccination drive is delivering measurable protection for teenagers, including those who later acquire HIV. New research led by scientists at Wits University shows the country’s school-based programme is sharply reducing infections with the two highest-risk HPV strains linked to cervical cancer. The vaccine used in the public programme targets HPV-16 and HPV-18, the strains responsible for around…
-
Perinatal Mental Health: Risks and Solutions in Pregnancy
As National Pregnancy Week runs from 3-7 February, the South African Society of Psychiatrists (Sasop) is calling on healthcare providers and expectant mothers to treat perinatal mental health symptoms in pregnancy as urgent medical issues. The society says between 16% and 50% of women in South Africa experience depression or anxiety during pregnancy. It adds that up to one in…